Learn about the most cutting-edge bacteriophage therapies used to combat diseases caused by multidrug-resistant bacteria”

Based on the most recent scientific studies, the number of deaths caused by antibiotic resistance is experiencing an increasing trend in recent years.  It is estimated that by 2050 it could be the leading cause of death in the world. This circumstance has led the healthcare community to focus its efforts on combating diseases caused by multi-resistant bacteria, developing cutting-edge therapies aimed at treating them more effectively. Therefore, pharmacists who are concerned about the approach to these infections must have an in-depth knowledge of them in order to meet the new challenges that exist in the healthcare field. 

With this idea in mind, TECH has decided to create this academic program, which will provide students with an intense update on Emerging Strategies Against Multidrug-Resistant Bacteria. Through this program, students will analyze the challenges presented by CRISPR-Cas9 gene editing, as well as the challenges and limitations of the temporary collateral sensitization method. In the same way, they will investigate the vaccines against the main multidrug-resistant bacteria that are in the process of development or the updated antibiotic combination therapies.

Thanks to the 100% online mode used in this program, pharmacists will be able to complete their professional update without having to make uncomfortable daily trips to a study center. Likewise, they will have the didactic content is available 24 hours a day and in a wide range of study formats such as readings, videos or interactive summaries. 

This will allow you to study at any time, achieving more effective learning and ensuring long-term knowledge acquisition.

Access your learning content from anywhere you want and from any electronic device to optimize your learning”

This Postgraduate certificate in Emerging Strategies Against Multidrug-Resistant Bacteria contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Microbiology, Medicine and Parasitology
• The graphic, schematic and eminently practical contents with which it is conceived gather scientific and practical information on those disciplines that are indispensable for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Identify the most current antibiotic combination therapies that are used to address the most current diseases caused by multidrug-resistant bacteria”

The program’s teaching staff includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will allow the professional a situated and contextual learning, that is, a simulated environment that will provide an immersive specialization programmed to prepare in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Thanks to this program, you will detect in which process are the vaccines in development oriented to combat the main multidrug-resistant bacteria"

Do you want to be updated on Emerging Strategies Against Multidrug-Resistant Bacteria without leaving your home? Get it with this program"

The syllabus of this program has been designed with the intention of updating pharmacists in the field of Emerging Strategies Against Multidrug-Resistant Bacteria, in a 100% online mode and without having to physically travel to the study centers. Therefore, during the 6 weeks of learning, they will investigate the modification of pathogens that allow the realization of more effective treatments for infectious diseases. Likewise, they will acquire a deep knowledge of the existing challenges in the development of antibacterial vaccines.

You will deepen your understanding of the challenges involved in the development of antibacterial vaccines through this program”

Module 1. Emerging Strategies for Multidrug-Resistant Bacteria

1.1. CRISPR-Cas9 Gene Editing

1.1.1. Molecular Mechanism of Action
1.1.2. Applications

1.1.2.1. CRISPR-Cas9 as a Therapeutic Tool
1.1.2.2. Engineering of Probiotic Bacteria
1.1.2.3. Rapid Detection of Resistance
1.1.2.4. Elimination of Resistance Plasmids
1.1.2.5. Development of New Antibiotics
1.1.2.6. Safety and Stability

1.1.3. Limitations and Challenges

1.2. Temporary Collateral Sensitization (SCT)

1.2.1. Molecular Mechanism
1.2.2. Advantages and Applications of SCT
1.2.3. Limitations and Challenges

1.3. Gene Silencing

1.3.1. Molecular Mechanism
1.3.2. RNA Interference
1.3.3. Antisense Oligonucleotides
1.3.4. Benefits and Applications of Gene Silencing
1.3.5. Limitations

1.4. High-Throughput Sequencing

1.4.1. Stages of High-Throughput Sequencing
1.4.2. Bioinformatics Tools for Combating Multidrug-Resistant Bacteria
1.4.3. Challenges

1.5. Nanoparticles

1.5.1. Mechanisms of Action against Bacteria
1.5.2. Clinical Applications
1.5.3. Limitations and Challenges

1.6. Engineering of Probiotic Bacteria

1.6.1. Production of Antimicrobial Molecules
1.6.2. Bacterial Antagonism
1.6.3. Modulation of the Immune System
1.6.4. Clinical Applications

1.6.4.1. Prevention of Nosocomial Infections
1.6.4.2. Reducing the Incidence of Respiratory Infections
1.6.4.3. Adjunctive Therapy in the Treatment of Urinary Tract Infections
1.6.4.4. Prevention of Resistant Skin Infections

1.6.5. Limitations and Challenges

1.7. Antibacterial Vaccines

1.7.1. Types of Vaccines against Diseases Caused by Bacteria
1.7.2. Vaccines in Development against Major Multidrug-Resistant Bacteria
1.7.3. Challenges and Considerations

1.8. Bacteriophages

1.8.1. Mechanism of Action
1.8.2. Lytic Cycle of Bacteriophages
1.8.3. Lysogenic Cycle of Bacteriophages

1.9. Phage Therapy

1.9.1. Isolation and Transport of Bacteriophages
1.9.2. Purification and Handling of Bacteriophages in the Laboratory
1.9.3. Phenotypic and Genetic Characterisation of Bacteriophages
1.9.4. Preclinical and Clinical Trials
1.9.5. Compassionate Use of Phages and Success Stories

1.10. Antibiotic Combination Therapy

1.10.1. Mechanisms of Action
1.10.2. Efficacy and Risks
1.10.3. Challenges and Constraints
1.10.4. Combined Antibiotic and Phage Therapy

Make the most of this opportunity to surround yourself with expert professionals and learn from their work methodology"